Responses to E-cigarette Message Source and Presentation

December 20, 2025 updated by: Donghee Nicole Lee, University of Massachusetts, Worcester

Identifying and Examining the Effects of Source and Presentation on Responses to Electronic Cigarette Public Education Messages in Young Adult Vapers and Non-vapers - Part 1

The goal of this clinical trial is to use crowdsourcing to test the effects of a message source (expert and peer) and message presentation types (one-sided and two-sided) to identify the optimal message type for young adults who vape and do not vape.

Study Overview

Study Type

Interventional

Enrollment (Actual)

848

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Worcester, Massachusetts, United States, 01605
        • UMass Chan Medical School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • US residents ages 18-24
  • Fluent in English
  • Reporting either vaping in the past 30 days or not having vaped in the past 30 days but susceptible to vaping

Exclusion Criteria:

  • Age less than 18 or above 24
  • Not fluent in English
  • Not a member of partnering crowdsourcing behavioral research platform conducting the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Expert, one-sided
Participants assigned to the expert, one-sidedness condition will receive one-sided e-cigarette messages from an expert source.
Participants will view a brief description of an expert source and see one-sided e-cigarette education messages.
Experimental: Expert, two-sided
Participants assigned to the expert, two-sidedness condition will receive two-sided e-cigarette messages from an expert source.
Participants will view a brief description of an expert source and see two-sided e-cigarette education messages.
Experimental: Peer, one-sided
Participants assigned to the peer, one-sidedness condition will receive one-sided e-cigarette messages from a peer source.
Participants will view a brief description of a peer source and see one-sided e-cigarette education messages.
Experimental: Peer, two-sided
Participants assigned to the peer, two-sidedness condition will receive two-sided e-cigarette messages from a peer source.
Participants will view a brief description of a peer source and see two-sided e-cigarette education messages.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Message Acceptance
Time Frame: After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.
Participants' self-reported message acceptance were measured by using a five-point Likert scale using five items assessing whether participants thought the message was worth remembering, grabbed their attention, powerful, convincing, and meaningful on a scale from 1 (Strongly disagree) to 5 (Strongly agree). Items were summed and averaged to create a single composite score, and this was done for each arm for each vaping status. Higher scores indicate more more message acceptance, therefore better outcomes.
After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.
Harm Perceptions
Time Frame: After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.
Harm perceptions was measured by a single item e-cigarette harm perceptions question assessing participants' perceived absolute harm of e-cigarette use on a scale from 1 (Not at all harmful) to 10 (Very harmful). Items were summed and averaged to create a single composite score. This was done for each vaping status (current vapers and susceptible non-vapers). Higher scores indicate greater vaping harm perceptions, therefore indicating better outcome.
After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Negative Cognition
Time Frame: After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.
Negative cognition was measured by six-item reactance questionnaire, such as perceptions of messages being manipulative, misleading, distorted, overblown, exaggerated, and overstated on a scale from 1 (Strongly disagree) to 5 (Strongly agree). Higher scores indicate greater negative cognition, indicating worse outcome.
After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.
Message Anger
Time Frame: After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.
Message anger was measured by four item message anger question assessing the extent to which the messages made participants feel irritated, angry, annoyed, and aggravated on a scale from 1 (not at all) to 5 (very much). Items were summed and averaged. This was done for each vaping status (current vapers and susceptible non-vapers). Higher scores indicate greater anger toward messages, indicating worse outcomes.
After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.
Message Liking
Time Frame: After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.
Message liking will be measured by a single-item liking of the message on scale from 1 (Dislike very much) to 5 (Like very much). Items were summed and averaged to create a single composite score. This was done for each vaping status (current vapers and susceptible non-vapers). Higher scores indicate greater message liking, therefore indicating better outcome.
After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.
Source Trust
Time Frame: After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.
Source trust was measured by a single-item trust in health information source questionnaire, such as trust in source about vaping information on a scale from 1(Not at all) to 5 (Very much so). Items were summed and averaged to create a single composite score. This was done for each vaping status (current vapers and susceptible non-vapers). Higher scores indicate greater source trust, therefore indicating better outcome
After exposure to each messages (approximately up to 20 minutes total), measured during a single study visit on Day 1.
Attitudes
Time Frame: After exposure to all messages (approximately up to 45 minutes), measured during a single study visit on Day 1.
Participants' self-reported vaping attitudes were measured by using a five-point bipolar scale using 7 subscale items assessing whether participants thought vaping was enjoyable, healthy, safe, fun, smart, cool, and attractive on a scale from 1 (negative attitudes) to 5 (positive attitudes). Items were summed and averaged to create a single composite score, and this was done for each arm for each vaping status. Higher scores indicate more positive e-cigarette attitudes, therefore worse outcomes.
After exposure to all messages (approximately up to 45 minutes), measured during a single study visit on Day 1.
Behavioral Intentions to Vape or Try Vaping
Time Frame: After exposure to all messages (approximately up to 45 minutes), measured during a single study visit on Day 1.
Participants' vaping or vaping trial intentions were measured by using a 3 subscale items assessing participants' intentions to vape: soon/anytime during the next year/would use offered by one of their best friends, on a scale from 1 (Definitely not) to 5 (Definitely yes). Items were summed and averaged to create a single composite score. This was done for each vaping status (current vapers and susceptible non-vapers). Higher scores indicate greater vaping intentions, therefore indicating worse outcome.
After exposure to all messages (approximately up to 45 minutes), measured during a single study visit on Day 1.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Donghee N Lee, PhD, UMass Chan Medical School

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2024

Primary Completion (Actual)

December 5, 2024

Study Completion (Actual)

December 17, 2024

Study Registration Dates

First Submitted

January 17, 2024

First Submitted That Met QC Criteria

February 20, 2024

First Posted (Actual)

February 23, 2024

Study Record Updates

Last Update Posted (Estimated)

January 14, 2026

Last Update Submitted That Met QC Criteria

December 20, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY00001220
  • 1K99CA281094-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vaping

Clinical Trials on Expert, one-sided

Subscribe